|From: kyleLennon (Rep: 0)||Date: 08/08/2018 23:00|
|Forum: Interpace Diagnostics Group - Msg #351||Thread #674026952 (Rec: 0) |
|Interpace Diagnostics Group stock popped recently because the company received a letter from NASDAQ about regaining compliance with the requirement to maintain a minimum closing bid price of $1.00 per share. This closing bid minimum has been maintained between July 16 and July 27. |
There are some positive commercial developments for the company. The mega-insurer Cigna stated it will cover ThyraMIR, a microRNA gene expression classifier for thyroid nodules, that Interpace Diagnostics developed.
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.